tiprankstipranks
Grifols SA (GRFS)
NASDAQ:GRFS

Grifols SA Stock Analysis & Ratings

GRFS Stock Chart & Stats

Day’s Range$12.84 - $13.15
52-Week Range$10.10 - $19.07
Previous Close$12.96
Volume594.09K
Average Volume (3M)1.00M
Market Cap$9.03B
P/E Ratio11.3
Beta0.43
Next EarningsJul 29, 2022
EPS ForecastN/A
Dividend Yield0.49 (3.77%)
Smart Score9
EPS (TTM)1.16


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

GRFS FAQ

What was Grifols SA’s price range in the past 12 months?
Grifols SA lowest stock price was $10.10 and its highest was $19.07 in the past 12 months.
    What is Grifols SA’s market cap?
    Grifols SA’s market cap is $9.03B.
      What is Grifols SA’s price target?
      The average price target for Grifols SA is $18.46. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $23.92 ,the lowest forecast is $13.00. The average price target represents 40.49% Increase from the current price of $13.14.
        What do analysts say about Grifols SA?
        Grifols SA’s analyst rating consensus is a ‘Hold. This is based on the ratings of 2 Wall Streets Analysts.
          When is Grifols SA’s upcoming earnings report date?
          Grifols SA’s upcoming earnings report date is Jul 29, 2022 which is in 73 days.
            How were Grifols SA’s earnings last quarter?
            Currently, no data Available
            Is Grifols SA overvalued?
            According to Wall Street analysts Grifols SA’s price is currently Undervalued.
              Does Grifols SA pay dividends?
              Grifols SA pays a Annually dividend of $0.34 which represents an annual dividend yield of 3.77%. Grifols SA’s last Annually dividend payment was on Jun 14, 2021. Grifols SA’s upcoming ex-dividend date is Jun 03, 2021
                What is Grifols SA’s EPS estimate?
                Grifols SA’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Grifols SA have?
                Grifols SA has 687,550,000 shares outstanding.
                  What happened to Grifols SA’s price movement after its last earnings report?
                  Currently, no data Available
                  Which hedge fund is a major shareholder of Grifols SA?
                  Among the largest hedge funds holding Grifols SA’s share is Brandes Investment Partners LP. It holds Grifols SA’s shares valued at 57M.

                    ---

                    Grifols SA Stock Analysis

                    Smart Score
                    9
                    Outperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    Price Target
                    $18.46
                    ▲(40.49% Upside)
                    Hold
                    The Grifols SA stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Grifols SA

                    Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Cerus
                    Abbott Labs
                    Johnson & Johnson
                    Amgen
                    Hologic

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis